Skip to Main Navigation

Sierra Leone COVID-19 Emergency Preparedness and Response Project

Abstract*

The proposed Project will be part of the COVID-19 Strategic Preparedness and Response Program using the Multiphase Programmatic Approach (MPA). The proposed Project build on the gains of Regional Disease Surveillance System Enhancement (REDISSE) Project, the Ebola Emergency Response Project (EERP) and the Health Service Delivery & Systems Support Project (HSDSSP). The proposed Project will fill critical financing gaps that have been identified due...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Sierra Leone.

Key Details

Project Details

  • P173803

  • Closed

  • Yohana Dukhan , Nicolas Rosemberg

  • Ministry of Finance

  • Sierra Leone

  • March 24, 2020

  • (as of board presentation)

    April 2, 2020

  • April 3, 2020

  • US$ 34.10 million

  • Ministry of Health and Sanitation

  • Western and Central Africa

  • 2020

  • US$ 34.10 million

  • N/A

  • March 27, 2024

  • June 30, 2023

  • No

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Grant 30.60
Health Emergency Preparedness and Response Multi-Donor Trust 3.50

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 30.60
IBRD + IDA Commitment 30.60
Lending Instrument
Grant Amount 3.50
Total Project Cost** 34.10

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Apr 7, 2020 IDA-D6030 Loan Disb 2,500,000.00
Nov 13, 2023 IDA-D9600 Loan Cancel 164,647.45
Jul 6, 2020 IDA-D6030 Loan Disb 158,268.30
Nov 12, 2020 IDA-D6030 Loan Disb 105,711.65
Aug 12, 2021 IDA-D8530 Loan Disb -200,000.00
Nov 22, 2021 IDA-D8530 Loan Disb 10,269.50
Mar 24, 2021 IDA-D6030 Loan Disb 823,141.80
Jul 29, 2021 IDA-D6030 Loan Disb 341,375.44
Jul 8, 2021 IDA-D8530 Loan Disb 1,000,000.00
Sep 22, 2021 IDA-D8530 Loan Disb 697,500.00
Nov 1, 2021 IDA-D6030 Loan Disb 1,089,113.80
Nov 30, 2021 IDA-D8530 Loan Disb 1,160,280.00
Jul 13, 2020 IDA-D6030 Loan Disb 2,095,550.00
Aug 5, 2020 IDA-D6030 Loan Disb 344,868.06
Dec 2, 2020 IDA-D6030 Loan Disb 35,711.03
Mar 30, 2023 IDA-D9600 Loan Cancel 13,093,585.00
Jan 28, 2022 IDA-D8530 Loan Disb 182,082.67
Nov 3, 2022 IDA-D9600 Loan Disb 2,500,000.00
Dec 16, 2021 IDA-D8530 Loan Disb 802,233.80
Oct 18, 2021 IDA-D8530 Loan Disb 1,160,280.00
Jun 7, 2023 IDA-D9600 Loan Cancel 1,471,919.50
Nov 13, 2023 IDA-D6030 Loan Disb -90,742.21
Nov 13, 2023 IDA-D6030 Loan Disb -48,053.39
Nov 13, 2023 IDA-D9600 Loan Disb -164,286.88
Nov 13, 2023 IDA-D6030 Loan Disb -1,270.33
Nov 13, 2023 IDA-D8530 Loan Disb -2,494.45
Nov 13, 2023 IDA-D9600 Loan Disb -359.63
Nov 13, 2023 IDA-D8530 Loan Disb -196,129.75
Nov 17, 2023 IDA-D6030 Loan Disb -795.96
Apr 28, 2023 IDA-D8530 Loan Disb -96,473.99
Dec 13, 2021 IDA-D9600 Loan Commitment 18,100,000.00
May 28, 2021 IDA-D8530 Loan Commitment 5,000,000.00
Apr 2, 2020 IDA-D6030 Loan Commitment 7,500,000.00
Feb 12, 2024 IDA-D6030 Loan Cancel 141,856.06
Sep 28, 2020 IDA-D6030 Loan Disb 146,566.80

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Procurement Satisfactory 2023-06-29
Financial Management Satisfactory 2023-06-29
Overall Implementation Progress (IP) Moderately Satisfactory 2023-06-29
Project Management Moderately Satisfactory 2023-06-29
Monitoring and Evaluation Moderately Satisfactory 2023-06-29
Progress towards achievement of PDO Satisfactory 2023-06-29

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Country has activated their public health Emergency Operations Center for COVID-19ValueNoYesYes
    DateMarch 20, 2020June 6, 2023June 30, 2023
    Comment
  • Suspected COVID-19 cases reported and investigated based on national guidelinesValue0.00100.0090.00
    DateMarch 20, 2020June 6, 2023June 30, 2023
    Comment
  • Designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents without stock-out in preceding two weeksValue0.005.003.00
    DateMarch 20, 2020June 6, 2023June 30, 2023
    Comment
  • Designated acute healthcare facilities with isolation capacityValue0.00100.0090.00
    DateMarch 20, 2020June 6, 2023June 30, 2023
    Comment
  • Population vaccinated, which is included in the target population groups defined in national vaccine deployment planValue0.0082.5051.60
    DateMarch 14, 2021June 6, 2023June 30, 2023
    Comment
  • Proportion of females among those vaccinatedValue0.0052.1050.00
    DateMarch 14, 2021June 6, 2023June 30, 2023
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Designated health facilities for COVID-19 treatment, laboratories and veterinary laboratories, regional and district hospitals reported, using eIDSR in preceding monthValue0.0095.0090.00
    DateMarch 20, 2020June 6, 2023June 30, 2023
    Comment
  • At least one multi- sectoral simulation exercise conducted with results incorporated into national COVID-19 preparedness and response plansValueNoNoYes
    DateMarch 20, 2020June 6, 2023June 30, 2023
    Comment
  • Designated laboratories with staff trained to conduct COVID-19 diagnosis per EOC protocolValue0.005.003.00
    DateMarch 20, 2020June 6, 2023June 30, 2023
    Comment
  • Country has reported to have contextualized risk communication and community engagement strategiesValueNoYesYes
    DateMarch 20, 2020June 6, 2023June 30, 2023
    Comment
  • Quarterly reports with IDSR data submitted in a timely mannerValue0.0016.0016.00
    DateMarch 14, 2021June 6, 2023June 30, 2023
    Comment
  • Country has established a sample referral system to care for COVID-19 patientsValueNoYesYes
    DateMarch 20, 2020June 6, 2023June 30, 2023
    Comment
  • Districts received monitoring and supportive supervision from the MoHS and/or the PBSL for COVID-19 vaccination in the preceding quarterValue0.0016.0016.00
    DateMarch 14, 2021June 6, 2023June 30, 2023
    Comment
  • Health workers and front line staff at the designated POEs and health and quarantine facilities for COVID-19 treatment trained in infection prevention and control per MOH-approved protocolsValue0.00150.0090.00
    DateMarch 20, 2020June 6, 2023June 30, 2023
    Comment
  • People having adequate knowledge on preventive measures from COVID-19Value81.0090.0095.00
    DateMarch 14, 2021June 6, 2023June 30, 2023
    Comment
  • Laboratory results available within 72 hoursValue0.00100.0080.00
    DateMarch 20, 2020June 6, 2023June 30, 2023
    Comment
  • Complaints at 117 and ACC received and addressed within one week through the project GRMValue0.00100.0080.00
    DateMarch 14, 2021June 6, 2023June 30, 2023
    Comment
  • Females having adequate knowledge on preventive measures from COVID-19Value0.0090.0095.00
    DateMarch 14, 2021June 6, 2023June 30, 2023
    Comment
  • Districts meeting their COVID-19 vaccination coverage targets for fully vaccinated personsValue0.0016.0016.00
    DateMarch 14, 2021June 6, 2023June 30, 2023
    Comment
  • People are willing to take COVID-19 vaccinesValue72.0090.0090.00
    DateMarch 14, 2021June 6, 2023June 30, 2023
    Comment
  • Districts reporting SMT on COVID-19 vaccines in the preceding monthValue0.0016.0016.00
    DateMarch 14, 2021June 6, 2023June 30, 2023
    Comment
  • Females are willing to take COVID-19 vaccinesValue0.0085.0090.00
    DateMarch 14, 2021June 6, 2023June 30, 2023
    Comment